| Configuration: Zeng et al. 2026 classifier: Combined All Features (1%) | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.455 AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) unitless · higher Uncertainty: SD 0.0819903025330799. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10). Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined All Features (1%) on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4c, row 4 'Combined All Features (1%)', column B 'mean_auc' |
|---|
| Configuration: Zeng et al. 2026 classifier: Combined All Features (1%) | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.236 Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) fraction · higher Uncertainty: ± 0.0966943340567746 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined All Features (1%) on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4d, row 8 'Combined All Features (1%)', column B 'mean_sens99' |
|---|
| Configuration: Zeng et al. 2026 classifier: Combined All Features (5%) | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.826 AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) unitless · higher Uncertainty: SD 0.0240123569351993. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10). Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined All Features (5%) on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4c, row 9 'Combined All Features (5%)', column B 'mean_auc' |
|---|
| Configuration: Zeng et al. 2026 classifier: Combined All Features (5%) | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.732 Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) fraction · higher Uncertainty: ± 0.0271256816745684 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined All Features (5%) on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4d, row 3 'Combined All Features (5%)', column B 'mean_sens99' |
|---|
| Configuration: Zeng et al. 2026 classifier: End Motifs | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.188 AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) unitless · higher Uncertainty: SD 0.0590546576842708. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10). Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceEnd Motifs on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4c, row 3 'End Motifs', column B 'mean_auc' |
|---|
| Configuration: Zeng et al. 2026 classifier: End Motifs | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.0222 Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) fraction · higher Uncertainty: ± 0.0104756560175785 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceEnd Motifs on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4d, row 11 'End Motifs', column B 'mean_sens99' |
|---|
| Configuration: Zeng et al. 2026 classifier: Fragment Ratio | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.848 AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) unitless · higher Uncertainty: SD 0.0182337453107787. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10). Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceFragment Ratio on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4c, row 10 'Fragment Ratio', column B 'mean_auc' |
|---|
| Configuration: Zeng et al. 2026 classifier: Fragment Ratio | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.533 Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) fraction · higher Uncertainty: ± 0.0936971158568409 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceFragment Ratio on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4d, row 5 'Fragment Ratio', column B 'mean_sens99' |
|---|
| Configuration: Zeng et al. 2026 classifier: Insert Size | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.698 AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) unitless · higher Uncertainty: SD 0.0519540926435662. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10). Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceInsert Size on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4c, row 7 'Insert Size', column B 'mean_auc' |
|---|
| Configuration: Zeng et al. 2026 classifier: Insert Size | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.0589 Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) fraction · higher Uncertainty: ± 0.0262153161024984 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceInsert Size on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4d, row 9 'Insert Size', column B 'mean_sens99' |
|---|
| Configuration: Zeng et al. 2026 classifier: Methylation | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.633 Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) fraction · higher Uncertainty: ± 0.0188852574577511 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceMethylation on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4d, row 4 'Methylation', column B 'mean_sens99' |
|---|
| Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation (1%) | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.0656 AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) unitless · higher Uncertainty: SD 0.0392812330449378. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10). Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined Motif + Methylation (1%) on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4c, row 2 'Combined Motif + Methylation (1%)', column B 'mean_auc' |
|---|
| Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation (1%) | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.0289 Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) fraction · higher Uncertainty: ± 0.0210818510677892 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined Motif + Methylation (1%) on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4d, row 10 'Combined Motif + Methylation (1%)', column B 'mean_sens99' |
|---|
| Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%) | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.514 AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) unitless · higher Uncertainty: SD 0.0760470615897827. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10). Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined Motif + Methylation + Ratios (1%) on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4c, row 5 'Combined Motif + Methylation + Ratios (1%)', column B 'mean_auc' |
|---|
| Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%) | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.317 Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) fraction · higher Uncertainty: ± 0.0833539069253844 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined Motif + Methylation + Ratios (1%) on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4d, row 7 'Combined Motif + Methylation + Ratios (1%)', column B 'mean_sens99' |
|---|
| Configuration: Zeng et al. 2026 classifier: Nucleosome Peak | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.756 AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) unitless · higher Uncertainty: SD 0.143223467137928. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10). Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNucleosome Peak on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4c, row 8 'Nucleosome Peak', column B 'mean_auc' |
|---|
| Configuration: Zeng et al. 2026 classifier: Nucleosome Peak | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.447 Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) fraction · higher Uncertainty: ± 0.212354008916433 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNucleosome Peak on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4d, row 6 'Nucleosome Peak', column B 'mean_sens99' |
|---|
| Configuration: Zeng et al. 2026 classifier: Combined Ratios + Methylation (1%) | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.954 AUROC (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) unitless · higher Uncertainty: SD 0.0200088799401821. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10). Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined Ratios + Methylation (1%) on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4c, row 11 'Combined Ratios + Methylation (1%)', column B 'mean_auc' |
|---|
| Configuration: Zeng et al. 2026 classifier: Combined Ratios + Methylation (1%) | Protocol: Zeng et al. 2026 independent PE validation dataset: cancer vs healthy Dataset: Zeng et al. 2026 independent paired-end validation dataset | 0.766 Sensitivity at 99% specificity (cancer vs healthy, independent PE validation dataset, mean over 10 fold models) fraction · higher Uncertainty: ± 0.0400445568022978 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceCombined Ratios + Methylation (1%) on pe validation (Zeng et al. 2026) ctdnalit-20261011-zeng2026-protocol-pe-validation Aggregation: Not reported A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4d, row 2 'Combined Ratios + Methylation (1%)', column B 'mean_sens99' |
|---|